Want to see JP:4528 full AI Analyst Report?

ONO Pharmaceutical Co (4528) Ratios

1 Followers

ONO Pharmaceutical Co Ratios

JP:4528's free cash flow for Q2 2026 was ¥0.73. For the 2026 fiscal year, JP:4528's free cash flow was decreased by ¥ and operating cash flow was ¥0.24. See a summary of the company’s cash flow.

Ratios	TTM	Mar 26	Mar 26	Mar 25	Mar 24
Liquidity Ratios
Current Ratio	―	3.07	2.86	3.99	2.81
Quick Ratio	―	2.56	2.51	3.52	2.44
Cash Ratio	―	1.38	1.45	1.60	0.78
Solvency Ratio	―	0.28	0.43	1.27	0.97
Operating Cash Flow Ratio	―	0.56	0.84	1.07	1.30
Short-Term Operating Cash Flow Coverage	―	2.75	3.87	47.90	64.10
Net Current Asset Value	¥ ―	¥ 179.26B	¥ 218.44B	¥ 298.53B	¥ 210.48B
Leverage Ratios
Debt-to-Assets Ratio	―	0.14	0.11	<0.01	0.01
Debt-to-Equity Ratio	―	0.19	0.14	0.01	0.01
Debt-to-Capital Ratio	―	0.16	0.12	0.01	0.01
Long-Term Debt-to-Capital Ratio	―	0.12	0.08	<0.01	<0.01
Financial Leverage Ratio	―	1.36	1.30	1.15	1.19
Debt Service Coverage Ratio	―	2.49	2.86	57.66	38.58
Interest Coverage Ratio	―	38.77	29.20	712.24	155.49
Debt to Market Cap	―	0.18	0.09	<0.01	<0.01
Interest Debt Per Share	―	315.77	264.92	18.94	6.88
Net Debt to EBITDA	―	-0.66	-0.87	-0.86	-0.54
Profitability Margins
Gross Profit Margin	―	68.90%	72.52%	74.71%	75.39%
EBIT Margin	―	12.52%	18.65%	32.62%	32.30%
EBITDA Margin	―	18.05%	25.97%	36.23%	36.20%
Operating Profit Margin	―	13.02%	20.03%	32.45%	31.75%
Pretax Profit Margin	―	12.19%	17.96%	32.57%	32.10%
Net Profit Margin	―	10.28%	13.53%	25.46%	25.21%
Continuous Operations Profit Margin	―	10.30%	13.55%	25.47%	25.25%
Net Income Per EBT	―	84.36%	75.30%	78.16%	78.54%
EBT Per EBIT	―	93.60%	89.66%	100.39%	101.11%
Return on Assets (ROA)	―	4.70%	6.31%	14.01%	12.77%
Return on Equity (ROE)	―	6.40%	8.20%	16.14%	15.19%
Return on Capital Employed (ROCE)	―	6.92%	10.96%	20.14%	18.69%
Return on Invested Capital (ROIC)	―	5.65%	7.95%	15.66%	14.61%
Return on Tangible Assets	―	7.02%	9.55%	14.94%	13.86%
Earnings Yield	―	6.65%	5.91%	10.80%	2.78%
Efficiency Ratios
Receivables Turnover	―	3.61	3.53	3.69	3.91
Payables Turnover	―	1.69	2.25	2.09	1.65
Inventory Turnover	―	2.02	2.47	2.61	2.46
Fixed Asset Turnover	―	4.61	5.09	4.80	4.12
Asset Turnover	―	0.46	0.47	0.55	0.51
Working Capital Turnover Ratio	―	1.58	1.69	1.89	2.04
Cash Conversion Cycle	―	66.35	89.11	64.17	20.48
Days of Sales Outstanding	―	101.22	103.27	98.80	93.37
Days of Inventory Outstanding	―	180.48	147.97	139.62	148.62
Days of Payables Outstanding	―	215.35	162.13	174.25	221.51
Operating Cycle	―	281.71	251.24	238.42	241.99
Cash Flow Ratios
Operating Cash Flow Per Share	―	175.56	291.20	230.50	108.95
Free Cash Flow Per Share	―	164.00	278.38	187.12	99.05
CapEx Per Share	―	11.56	12.82	43.39	9.90
Free Cash Flow to Operating Cash Flow	―	0.93	0.96	0.81	0.91
Dividend Paid and CapEx Coverage Ratio	―	1.92	3.14	1.91	3.61
Capital Expenditure Coverage Ratio	―	15.18	22.71	5.31	11.01
Operating Cash Flow Coverage Ratio	―	0.56	1.13	12.49	17.41
Operating Cash Flow to Sales Ratio	―	0.17	0.27	0.22	0.36
Free Cash Flow Yield	―	10.23%	11.09%	7.58%	3.58%
Valuation Ratios
Price-to-Earnings (P/E) Ratio	―	15.04	16.91	9.26	35.92
Price-to-Sales (P/S) Ratio	―	1.55	2.29	2.36	9.06
Price-to-Book (P/B) Ratio	―	0.96	1.39	1.49	5.46
Price-to-Free Cash Flow (P/FCF) Ratio	―	9.77	9.02	13.19	27.91
Price-to-Operating Cash Flow Ratio	―	9.13	8.62	10.71	25.37
Price-to-Earnings Growth (PEG) Ratio	―	-0.25	0.43	0.60	0.85
Price-to-Fair Value	―	0.96	1.39	1.49	5.46
Enterprise Value Multiple	―	7.91	7.94	5.64	24.48
Enterprise Value	―	694.79B	1.06T	1.03T	3.96T
EV to EBITDA	―	7.91	7.94	5.64	24.48
EV to Sales	―	1.43	2.06	2.04	8.86
EV to Free Cash Flow	―	9.02	8.13	11.44	27.31
EV to Operating Cash Flow	―	8.43	7.77	9.29	24.83
Tangible Book Value Per Share	―	930.34	1.02K	1.54K	463.25
Shareholders’ Equity Per Share	―	1.67K	1.81K	1.65K	506.38
Tax and Other Ratios
Effective Tax Rate	―	0.15	0.25	0.22	0.21
Revenue Per Share	―	1.04K	1.10K	1.05K	305.24
Net Income Per Share	―	106.55	148.49	266.57	76.94
Tax Burden	―	0.84	0.75	0.78	0.79
Interest Burden	―	0.97	0.96	1.00	0.99
Research & Development to Revenue	―	0.31	0.29	0.22	0.21
SG&A to Revenue	―	0.25	0.24	0.15	0.15
Stock-Based Compensation to Revenue	―	0.00	0.00	0.00	0.00
Income Quality	―	1.65	1.96	0.86	1.11

Currency in JPY